Charles Schwab Investment Management Inc. Decreases Holdings in Enhabit, Inc. (NYSE:EHAB)

Charles Schwab Investment Management Inc. reduced its stake in Enhabit, Inc. (NYSE:EHAB) by 39.7% during the fourth quarter, according to its most recent filing with the SEC. The fund owned 375,116 shares of the company’s stock after selling 246,453 shares during the quarter. Charles Schwab Investment Management Inc. owned 0.75% of Enhabit worth $2,930,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Victory Capital Management Inc. bought a new stake in Enhabit in the third quarter worth about $239,000. Intech Investment Management LLC purchased a new stake in shares of Enhabit during the 3rd quarter worth approximately $96,000. Dynamic Technology Lab Private Ltd bought a new stake in shares of Enhabit in the 3rd quarter worth approximately $215,000. FMR LLC lifted its stake in Enhabit by 138.4% in the third quarter. FMR LLC now owns 3,388 shares of the company’s stock valued at $27,000 after purchasing an additional 1,967 shares during the last quarter. Finally, Walleye Capital LLC bought a new position in Enhabit during the third quarter valued at $338,000.

Enhabit Stock Performance

NYSE EHAB opened at $8.92 on Friday. The firm has a market cap of $450.03 million, a P/E ratio of -3.84 and a beta of 1.80. The company has a quick ratio of 1.46, a current ratio of 1.46 and a debt-to-equity ratio of 0.85. The company’s 50 day moving average is $8.51 and its 200-day moving average is $7.97. Enhabit, Inc. has a 12-month low of $6.85 and a 12-month high of $11.74.

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group restated a “buy” rating on shares of Enhabit in a research note on Thursday, March 6th.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.